Rohto Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	82,851	77,161	89,210	79,951	72,791
Short-Term Investments	3,965	-	-	-	-
Cash & Short-Term Investments	86,816	77,161	89,210	79,951	72,791
Cash Growth	12.51%	-13.51%	11.58%	9.84%	37.44%
Accounts Receivable	52,255	69,880	69,115	60,656	51,682
Other Receivables	24,592	-	-	-	-
Receivables	76,847	69,880	69,115	60,656	51,682
Inventory	65,677	61,580	46,657	41,062	33,527
Other Current Assets	9,934	9,258	9,777	8,577	6,306
Total Current Assets	239,274	217,879	214,759	190,246	164,306
Property, Plant & Equipment	93,011	90,451	68,607	66,182	62,839
Long-Term Investments	55,904	46,649	43,731	32,629	27,471
Goodwill	34,242	47,494	2,285	2,564	2,954
Other Intangible Assets	49,656	8,575	6,932	6,997	6,338
Long-Term Deferred Tax Assets	4,154	3,975	3,869	5,371	5,297
Long-Term Deferred Charges	87	99	-	-	-
Other Long-Term Assets	2,458	2	2	1	2
Total Assets	485,771	421,875	346,175	309,677	274,627
Accounts Payable	20,937	22,056	21,123	18,718	16,269
Accrued Expenses	27,218	24,364	25,720	24,362	19,354
Short-Term Debt	24,742	7,035	5,304	4,177	8,033
Current Income Taxes Payable	6,572	6,963	6,643	6,230	3,185
Other Current Liabilities	37,880	34,190	28,297	26,675	24,647
Total Current Liabilities	117,349	94,608	87,087	80,162	71,488
Long-Term Debt	28,188	43,188	5,190	7,516	13,350
Long-Term Leases	7,314	-	-	-	-
Pension & Post-Retirement Benefits	707	1,770	2,548	3,104	3,332
Long-Term Deferred Tax Liabilities	10,767	2,081	1,597	1,173	1,450
Other Long-Term Liabilities	1,274	8,789	2,720	2,645	1,177
Total Liabilities	165,599	150,436	99,142	94,600	90,797
Common Stock	6,504	6,504	6,504	6,504	6,504
Additional Paid-In Capital	-	-	4,516	5,292	5,787
Retained Earnings	256,618	228,442	209,399	184,005	162,195
Treasury Stock	-9,939	-9,939	-4,939	-4,938	-4,936
Comprehensive Income & Other	48,643	35,087	30,843	18,706	8,737
Total Common Equity	301,826	260,094	246,323	209,569	178,287
Minority Interest	18,346	11,345	710	5,508	5,543
Shareholders' Equity	320,172	271,439	247,033	215,077	183,830
Total Liabilities & Equity	485,771	421,875	346,175	309,677	274,627
Total Debt	60,244	50,223	10,494	11,693	21,383
Net Cash (Debt)	26,572	26,938	78,716	68,258	51,408
Net Cash Growth	-1.36%	-65.78%	15.32%	32.78%	14.58%
Net Cash Per Share	112.85	117.69	344.04	298.33	224.69
Filing Date Shares Outstanding	225.96	225.96	228.14	228.14	228.14
Total Common Shares Outstanding	225.96	225.96	228.14	228.14	228.14
Working Capital	121,925	123,271	127,672	110,084	92,818
Book Value Per Share	1335.72	1151.04	1079.71	918.60	781.48
Tangible Book Value	217,928	204,025	237,106	200,008	168,995
Tangible Book Value Per Share	964.44	902.91	1039.31	876.69	740.75
Land	17,756	-	-	-	-
Buildings	80,296	-	-	-	-
Machinery	111,031	-	-	-	-
Construction In Progress	5,147	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.